Insider Transactions in Q4 2023 at Enanta Pharmaceuticals Inc (ENTA)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2023
|
Terry Vance Director |
SELL
Open market or private sale
|
Direct |
15,295
-72.51%
|
$137,655
$9.12 P/Share
|
|
Dec 05
2023
|
Brendan Luu Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,125
-5.47%
|
$19,125
$9.63 P/Share
|
|
Dec 05
2023
|
Nathaniel S. Gardiner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,412
-3.42%
|
$21,708
$9.63 P/Share
|
|
Dec 05
2023
|
Tara Lynn Kieffer Chief Product Strategy Officer |
SELL
Open market or private sale
|
Direct |
2,125
-5.4%
|
$19,125
$9.63 P/Share
|
|
Dec 05
2023
|
Paul J Mellett Chief Fin. & Admin Officer |
SELL
Open market or private sale
|
Direct |
2,412
-2.51%
|
$21,708
$9.63 P/Share
|
|
Dec 05
2023
|
Yat Sun Or Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,412
-0.65%
|
$21,708
$9.63 P/Share
|
|
Dec 05
2023
|
Scott T. Rottinghaus Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
534
-1.98%
|
$4,806
$9.63 P/Share
|
|
Dec 05
2023
|
Jay R. Luly President and CEO |
SELL
Open market or private sale
|
Direct |
7,230
-0.89%
|
$65,070
$9.63 P/Share
|
|
Dec 01
2023
|
Tara Lynn Kieffer Chief Product Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
753
-1.88%
|
$6,777
$9.49 P/Share
|
|
Dec 01
2023
|
Brendan Luu Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
753
-1.9%
|
$6,777
$9.49 P/Share
|
|
Dec 01
2023
|
Yat Sun Or Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,595
-0.43%
|
$14,355
$9.49 P/Share
|
|
Dec 01
2023
|
Nathaniel S. Gardiner Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,595
-2.21%
|
$14,355
$9.49 P/Share
|
|
Dec 01
2023
|
Paul J Mellett Chief Fin. & Admin Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,595
-1.64%
|
$14,355
$9.49 P/Share
|
|
Dec 01
2023
|
Jay R. Luly President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,787
-0.71%
|
$52,083
$9.49 P/Share
|